Maria Ferrer Aporta
Featured in: 
biorxiv.org
Articles
-
Nov 11, 2024 |
biorxiv.org | ANA GARCÍA |Ana Garcia |Antonio Trujillo |Maria Ferrer Aporta |German Vallejo Palma
AbstractPancreatic ductal adenocarcinoma (PDAC) is a devastating disease, marked by a survival rate of only 12%. Consequently, the exploration of novel therapeutic strategies becomes a critical clinical imperative. Among the genetic alterations contributing to PDAC, c-MYC overexpression arises due to upstream mutations, amplifications, and copy number alterations.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →